Verona Pharma PLC ADR Financial Flexibility Index
Verona Pharma PLC ADR financial flexibility index. Verona Pharma PLC ADR (VRNA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of $30.56 Million (operating CF $30.56 Million minus capex $0.00) represents 0% of total liabilities ($294.60 Million). Explore VRNA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Verona Pharma PLC ADR (2005–2024)
Financial flexibility index of Verona Pharma PLC ADR from 2005 to 2024. Historical Financial Flexibility Index trend for Verona Pharma PLC ADR across 20 annual periods. Check Verona Pharma PLC ADR total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Verona Pharma PLC ADR Financial Flexibility Index by Year (2005–2024)
Verona Pharma PLC ADR financial flexibility index by year from 2005 to 2024. Year-by-year free cash flow to debt coverage for Verona Pharma PLC ADR. For the full cash flow conversion analysis, see Verona Pharma PLC ADR (VRNA) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | $-121.62 Million | $-122.20 Million | $269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | $-50.22 Million | $-50.22 Million | $58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | $-59.83 Million | $-59.86 Million | $29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | $-33.24 Million | $-33.25 Million | $38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | $-44.99 Million | $-45.08 Million | $19.35 Million | ▲ +21.9% |
| 2019 | -2.98x | $-43.97 Million | $-44.34 Million | $14.78 Million | ▼ -88.9% |
| 2018 | -1.58x | $-22.64 Million | $-22.98 Million | $14.37 Million | ▲ +26.0% |
| 2017 | -2.13x | $-27.68 Million | $-27.97 Million | $13.00 Million | ▼ -355.0% |
| 2016 | -0.47x | $-6.74 Million | $-6.89 Million | $14.40 Million | ▲ +86.3% |
| 2015 | -3.43x | $-9.20 Million | $-9.41 Million | $2.69 Million | ▲ +45.9% |
| 2014 | -6.33x | $-5.17 Million | $-5.51 Million | $816.08K | ▼ -59.1% |
| 2013 | -3.98x | $-3.21 Million | $-3.39 Million | $806.89K | ▲ +67.6% |
| 2012 | -12.30x | $-3.96 Million | $-4.08 Million | $322.11K | ▼ -24.1% |
| 2011 | -9.91x | $-2.40 Million | $-2.44 Million | $242.21K | ▼ -26.7% |
| 2010 | -7.82x | $-2.49 Million | $-2.56 Million | $317.94K | ▼ -40.7% |
| 2009 | -5.56x | $-2.58 Million | $-2.62 Million | $464.08K | ▲ +64.8% |
| 2008 | -15.81x | $-1.94 Million | $-1.98 Million | $123.01K | ▼ -108.9% |
| 2007 | -7.57x | $-2.36 Million | $-2.39 Million | $311.35K | ▼ -48.6% |
| 2006 | -5.09x | $-658.29K | $-687.68K | $129.31K | ▼ -3154.5% |
| 2005 | 0.17x | $3.44K | $3.44K | $20.65K | — |